Asarfi Hospital Ltd
Asarfi Hospital Q1 FY27: Revenue ₹47.5 Cr, PAT ₹4.27 Cr
Q1 FY27 investor presentation: what the company reported on revenue, margins and projects.
Based on Asarfi Hospital Ltd's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentationreports, not management guidance.
The short version
Q1'FY27 consolidated revenue from operations: ₹47.5 Cr, up 32.8% YoY (vs ₹35.7 Cr in Q1'FY26) - Standalone revenue: ₹47.34 Cr, up 33.2% YoY (vs ₹35.66 Cr in Q1'FY26) - IPD patient volume growth: + EBITDA for Q1’FY27: ₹9.42 Cr (Consolidated), up 33.9% YoY from ₹7.03 Cr in Q1’FY26.
From Asarfi Hospital Ltd's Q1 FY27 earnings-call transcript · updated 9 Oct 2026.
Revenue & Sales Performance
- Q1'FY27 consolidated revenue from operations: ₹47.5 Cr, up 32.8% YoY (vs ₹35.7 Cr in Q1'FY26)
- Standalone revenue: ₹47.34 Cr, up 33.2% YoY (vs ₹35.66 Cr in Q1'FY26)
- IPD patient volume growth: +7% YoY in Q1'FY27
- OPD patient volume growth: +12% YoY in Q1'FY27
- IPD revenue growth: +31% YoY in Q1'FY27
- OPD revenue growth: +44% YoY in Q1'FY27
- Total surgery count increased from 1,549 in Q1’FY26 to 1,980 in Q1’FY27 (+28%)
- Bed capacity: 350 total (285 Super-Specialty + 65 Cancer Unit)
2 more points from Asarfi Hospital Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Asarfi Hospital Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Cancer Hospital Construction and Operation
- Construction started in 2022, operationalized in 2024.
- Initial capacity: 50 beds.
- Status: Operational since 2024.
- Asarfi Hospital Expansions
- Phase 1 expansion completed in 2016: Increased bed capacity to 120 beds.
- Phase 2 expansion in 2017: Established Cardiac Department, started Block-B construction.
- 2025 Strategic Partnership
- MoU signed with Gleneagles Hospital, Chennai to set up Jharkhand’s 1st Multi-Organ Transplant Unit.
- Timeline: Planned for 2025 onward.
- Technology Upgradation in 2026
- Installed GE Healthcare Dual-Detector SPECT Gamma Camera at Cancer Institute.
- Upgraded Cath Lab with Philips Azurion 5 M12 Image-Guided Therapy System.
- Installed Jharkhand's first Linear Accelerator “Varian True Beam.”
- Status: Completed/upgraded in 2026.
2 more points from Asarfi Hospital Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Asarfi Hospital Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Asarfi Hospital Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹45 Cr, net profit ₹4 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Asarfi Hospital's management said in earlier quarters
Others in Healthcare Services this season
- Aatmaj Healthcare Ltd (Q1 FY27)
Revenue for Q1 FY 2026-27: ₹8.13 crore . Key investor presentation takeaways from Aatmaj Healthcare Ltd's Q1 FY27 investor presentation — and how it ranks again
- KMC Speciality (Q1 FY27)
Q1 FY'27 Revenue from operations: INR 91.8 Cr, up 38% YoY from INR 66.6 Cr in Q1 FY'26. Key concall takeaways from KMC Speciality Hospitals (India) Ltd's Q1…
- 3B Blackbio (Q1 FY27)
Q1 2026-27 revenue from operations: ₹3,205.73 Lakh (including Coris sales of ₹862.83 Lakh) vs ₹1,996.06 Lakh in Q1 2025-26 — YoY growth approx. Key concall…
- Thyrocare Tech. (Q1 FY27)
Pathology business grew ~27%; franchisee business grew ~23-27% YoY, reflecting strong volume growth. Key concall takeaways from Thyrocare Technologies Ltd's Q1…
Arthneeti Pro · Annual
Asarfi Hospital Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Asarfi Hospital Ltd Q1 FY27 results?
Q1'FY27 consolidated revenue from operations: ₹47.5 Cr, up 32.8% YoY (vs ₹35.7 Cr in Q1'FY26) - Standalone revenue: ₹47.34 Cr, up 33.2% YoY (vs ₹35.66 Cr in Q1'FY26) - IPD patient volume growth: + EBITDA for Q1’FY27: ₹9.42 Cr (Consolidated), up 33.9% YoY from ₹7.03 Cr in Q1’FY26.
What is Asarfi Hospital Ltd share price analysis?
Asarfi Hospital Ltd currently shows a neutral. The stock trades at a P/E of 19.2 with a market cap of ₹349 Cr. Investors should review the full earnings analysis for detailed insights.
Is Asarfi Hospital Ltd planning capital expenditure?
Cancer Hospital Construction and Operation - Construction started in 2022, operationalized in 2024.
Keep Asarfi Hospital Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.